News

Eli Lilly said clinical results of its GLP-1 in pill form showed safety and efficacy data similar to blockbuster injectable ...
Employers face rising GLP-1 demand. Here are tips to manage costs while maintaining care access.
Eli Lilly shares are now positive for the year, up 10% since the start of January.
Eli Lilly's experimental pill worked as well as blockbuster drug Ozempic to lower weight and blood sugar in a trial of ...
The state’s largest commercial health insurer will stop covering a popular class of prescription drugs for weight loss, ...
Novo Nordisk, the maker of Ozempic and Wegovy, has also jumped into the legal fight —this time by intervening in the OFA’s lawsuit against the FDA. The company supports the agency’s move to restrict ...
As an affordability crisis grows in pricey New England, the rising cost of prescription drugs is squeezing patients, health ...